Hepatocellular enzyme elevations in a patient receiving ceftriaxone.
Rivkin
Anastasia M
AM
Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, 75 DeKalb Avenue, Brooklyn, NY 11201, USA. anastasia.rivkin@liu.edu
D000328:Adult; D000410:Alanine Transaminase / Q000097:blood; D000900:Anti-Bacterial Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001219:Aspartate Aminotransferases / Q000097:blood; D002443:Ceftriaxone / Q000009:adverse effects* / Q000627:therapeutic use; D003422:Critical Care; D022781:Hepatocytes / Q000201:enzymology*; D006801:Humans; D008111:Liver Function Tests; D008297:Male; D011008:Pneumococcal Infections / Q000188:drug therapy
D000900:Anti-Bacterial Agents; D002443:Ceftriaxone; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase